Keyphrases
Meta-analysis
100%
Systemic Review
100%
Progression-free Survival
100%
Radiological Assessment
100%
Review Analysis
100%
Metastatic Breast Cancer
100%
Restaging
100%
Hazard Ratio
55%
Overall Survival
33%
High Magnitude
22%
Statistical Significance
11%
Randomized Controlled Trial
11%
Confidence Interval
11%
Subgroup Analysis
11%
Human Epidermal Growth Factor Receptor 2 (HER2)
11%
Survival Effect
11%
Survival Benefit
11%
Antineoplastic Drugs
11%
Overall Survival Benefit
11%
Randomized Phase III Trial
11%
Interval Ratio
11%
Medicine and Dentistry
Meta-Analysis
100%
Progression Free Survival
100%
Metastatic Breast Cancer
100%
Hazard Ratio
55%
Overall Survival
44%
Randomized Controlled Trial
22%
Disease
11%
Awareness
11%
Population Research
11%
Subgroup Analysis
11%
Anticarcinogen
11%
Epidermal Growth Factor Receptor 2
11%
Gamma Urogastrone
11%
Neuroscience
Meta-Analysis
100%
Randomized Controlled Trial
100%
Epidermal Growth Factor Receptor 2
50%
Anticarcinogen
50%
Gamma Urogastrone
50%
Antineoplastic Drugs
50%
Pharmacology, Toxicology and Pharmaceutical Science
Progression Free Survival
100%
Metastatic Breast Cancer
100%
Overall Survival
44%
Randomized Controlled Trial
22%
Disease
11%
Population Study
11%
Anticarcinogen
11%
Epidermal Growth Factor Receptor 2
11%
Gamma Urogastrone
11%
Psychology
Meta-Analysis
100%
Breast Cancer
100%
Hazard Ratio
100%
Study Design
20%
Biochemistry, Genetics and Molecular Biology
Progression Free Survival
100%
Overall Survival
44%
Randomized Controlled Trial
22%
Population Research
11%
Awareness
11%
Epidermal Growth Factor Receptor
11%